BELITE BIO, INC (BLTE) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BLTE currently has 39.3M outstanding shares. with moderate dilution risk from 13M authorized shares representing 33.1% potential dilution. The company has diluted shareholders by 23.61% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 31, 2026 |
20-F filing | 39.3M shares outstanding |
39M | 13M |
| Mar 17, 2025 |
20-F filing | 31.8M shares outstanding |
32M | 13M |
| Mar 12, 2024 |
20-F filing | 29.1M shares outstanding |
29M | 13M |
| May 22, 2023 |
F-3 filing: Belite Bio, Inc files an F-3 form to offer and sell up to $300,000,000 of various securities, including American Depositary Shares, ordinary shares, preferred shares, warrants, overallotment purchase rights, subscription rights, units, capital notes and/or debt securities. |
10M | 13M |
| May 01, 2023 |
F-3 filing: Belite Bio, Inc files an F-3 to offer up to $300,000,000 of American Depositary Shares representing ordinary shares. |
10M | 0 |
| Mar 31, 2023 |
20-F filing | 10.3M shares outstanding |
10M | 0 |
| Apr 05, 2022 |
F-1 filing: This is an F-1 filing related to an offering of common stock. The Benchmark Company is listed as the book-running manager. |
N/A | 0 |